InspireMD, Inc. EPS (Diluted) for the Trailing 12 Months (TTM) ending March 31, 2025: USD -0.59

InspireMD, Inc. EPS (Diluted) is USD -0.59 for the Trailing 12 Months (TTM) ending March 31, 2025, a -30.82% change year over year. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.
  • InspireMD, Inc. EPS (Diluted) for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -0.85, a -63.04% change year over year.
  • InspireMD, Inc. EPS (Diluted) for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -2.30, a 10.05% change year over year.
  • InspireMD, Inc. EPS (Diluted) for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -2.09, a -64.70% change year over year.
  • InspireMD, Inc. EPS (Diluted) for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -5.92, a -89.75% change year over year.
Key Data
Date EPS (Diluted) Shares (Diluted, Weighted) Selling, General, and Administrative Expenses (SG&A) Research and Development (R&D) Expenses